Phenotype of schizophrenia: a review and formulation

Molecular Psychiatry
Carol A Tamminga, Henry H Holcomb

Abstract

The discovery of the pathophysiology(ies) for schizophrenia is necessary to direct rational treatment directions for this brain disorder. Firm knowledge about this illness is limited to areas of phenomenology, clinical electrophysiology, and genetic risk; some aspects of dopamine pharmacology, cognitive symptoms, and risk genes are known. Basic questions remain about diagnostic heterogeneity, tissue neurochemistry, and in vivo brain function. It is an illness ripe for molecular characterization using a rational approach with a confirmatory strategy; drug discovery based on knowledge is the only way to advance fully effective treatments. This paper reviews the status of general knowledge in this area and proposes an approach to discovery, including identifying brain regions of dysfunction and subsequent localized, hypothesis-driven molecular screening.

References

Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleR S Frackowiak
May 25, 1991·Lancet·E O'CallaghanR M Murray
Nov 1, 1991·The American Journal of Psychiatry·K L DavisM Davidson
Mar 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·J L MartinotA Syrota
Mar 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·S ArndtN C Andreasen
Mar 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·P F Liddle, D L Morris
Jul 1, 1991·Archives of General Psychiatry·A J SaykinP Stafiniak
Jul 1, 1991·Archives of General Psychiatry·S E ArnoldA R Damasio
Apr 1, 1990·Psychiatry Research·F MacciardiE Smeraldi
Jan 1, 1990·Modern Problems of Pharmacopsychiatry·T R Barnes, P F Liddle
Nov 1, 1990·The American Journal of Psychiatry·P E BartaL E Tune
Nov 1, 1990·Archives of General Psychiatry·T E GoldbergD R Weinberger
Jan 1, 1990·Schizophrenia Bulletin·S R Kay, S Sevy
Mar 22, 1990·The New England Journal of Medicine·R L SuddathD R Weinberger
Sep 1, 1990·Archives of General Psychiatry·C E BarrP Munk-Jorgensen
Feb 1, 1990·Archives of General Psychiatry·D L Braff, M A Geyer
Feb 1, 1989·Clinical Neuropharmacology·S I DeutschJ M Morihisa
Jan 1, 1989·Schizophrenia Bulletin·F M Benes
Aug 1, 1989·Archives of General Psychiatry·J M CleghornB Szechtman
Oct 1, 1989·Archives of General Psychiatry·R E Kendell, I W Kemp
Nov 1, 1989·Archives of General Psychiatry·D V Jeste, J B Lohr
Apr 1, 1987·Psychiatry Research·E R KorpiD R Weinberger
Apr 1, 1989·The American Journal of Psychiatry·R L SuddathD R Weinberger
Dec 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·B Pakkenberg
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Nov 1, 1987·Archives of General Psychiatry·N ColterC Bruton

❮ Previous
Next ❯

Citations

Aug 27, 2009·Cellular and Molecular Life Sciences : CMLS·José L MorenoJavier González-Maeso
Jan 13, 2010·Psychopharmacology·Laura M RowlandHenry H Holcomb
Mar 12, 2008·Annals of Biomedical Engineering·Andreas WindemuthGualberto Ruaño
Jun 15, 2010·Current Psychiatry Reports·David Feifel, Paul D Shilling
Jun 27, 2008·The Behavioral and Brain Sciences·Bernard Crespi, Christopher Badcock
Aug 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Falk W LohoffWade H Berrettini
Mar 20, 2009·The Australian and New Zealand Journal of Psychiatry·Maryam NesvaderaniSinthuja Sivagnanasundaram
May 16, 2008·Epidemiologic Reviews·John McGrathJoy Welham
Dec 1, 2007·Schizophrenia Bulletin·John McGrath
Sep 6, 2007·Proceedings. Biological Sciences·Bernard CrespiSteve Dorus
Sep 12, 2008·Biological Reviews of the Cambridge Philosophical Society·Bernard Crespi
May 7, 2011·Genes, Brain, and Behavior·S VuillermotU Meyer
Mar 13, 2012·Pharmacological Reviews·Anita E Autry, Lisa M Monteggia
Jan 21, 2006·BMJ : British Medical Journal·David M FergussonJoseph M Boden
Sep 13, 2007·PloS One·Thomas HansenThomas Werge
Jan 21, 2011·Journal of Psychiatry & Neuroscience : JPN·Noah L LazarDonald P Cain
Sep 22, 2010·Drug Design, Development and Therapy·Maria Rosaria A MuscatelloRocco Zoccali
Jan 16, 2010·The Australian and New Zealand Journal of Psychiatry·Cynthia Shannon WeickertClive Harper
Sep 20, 2006·Pharmacogenomics·Daniel J Müller, James L Kennedy
Jan 15, 2014·Cellular and Molecular Life Sciences : CMLS·Boris B QuednowMoritz J Rossner
Dec 13, 2006·Behavior Genetics·Edwin van den OordJaime Robles
Apr 7, 2015·Molekuliarnaia biologiia·D Iu GalaktionovaT V Nasedkina
Sep 28, 2010·Annual Review of Pharmacology and Toxicology·Hisham M Ibrahim, Carol A Tamminga
Jul 1, 2005·Current Neurology and Neuroscience Reports·Alison R PrestonAnthony D Wagner
Oct 5, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Melissa Mahgoub, Lisa M Monteggia
Oct 18, 2011·Cellular and Molecular Life Sciences : CMLS·H A TejedaR Henriksson
Aug 2, 2014·Expert Opinion on Pharmacotherapy·Maria Rosaria Anna MuscatelloRocco Antonio Zoccali
Sep 21, 2012·Expert Opinion on Drug Safety·Evangelos KaramatskosDieter Naber
Jan 28, 2010·Expert Opinion on Pharmacotherapy·Falk W Lohoff, Thomas N Ferraro
Jan 11, 2013·L'Encéphale·M AdidaN Corréard
Nov 3, 2012·Neuroscience Research·Yan ZhouGang Hu
Feb 4, 2012·Neuropharmacology·Hannah K DelilleMario Mezler
Aug 13, 2015·Journal of Autism and Developmental Disorders·Jennifer H Foss-FeigJulie Wolf
Jun 28, 2011·Trends in Pharmacological Sciences·Daniel J Lodge, Anthony A Grace
Jun 15, 2011·Progress in Neurobiology·Viola Oertel-KnöchelHarald Hampel
Apr 19, 2011·Schizophrenia Research·Frankie H F LeeAlbert H C Wong
Sep 4, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lukasz BojarskiUrszula Wojda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.